A detailed history of Aevitas Wealth Management, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Aevitas Wealth Management, Inc. holds 13,340 shares of NVS stock, worth $1.3 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
13,340
Previous 13,235 0.79%
Holding current value
$1.3 Million
Previous $1.01 Million 20.28%
% of portfolio
0.72%
Previous 0.76%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023

BUY
$75.55 - $92.52 $7,932 - $9,714
105 Added 0.79%
13,340 $0
Q2 2022

Jul 22, 2022

SELL
$80.52 - $93.75 $8,454 - $9,843
-105 Reduced 0.79%
13,235 $1.12 Million
Q1 2022

Apr 25, 2022

SELL
$80.11 - $90.62 $3,925 - $4,440
-49 Reduced 0.37%
13,340 $1.17 Million
Q4 2021

Jan 19, 2022

SELL
$79.7 - $88.13 $384,154 - $424,786
-4,820 Reduced 26.47%
13,389 $1.17 Million
Q2 2021

Jul 22, 2021

BUY
$85.24 - $94.15 $55,150 - $60,915
647 Added 3.68%
18,209 $1.66 Million
Q1 2021

Apr 29, 2021

BUY
$83.5 - $98.47 $767,114 - $904,643
9,187 Added 109.7%
17,562 $1.5 Million
Q1 2020

Apr 16, 2020

BUY
$70.67 - $99.01 $11,377 - $15,940
161 Added 1.96%
8,375 $691,000
Q3 2019

Oct 21, 2019

SELL
$85.54 - $94.26 $17,108 - $18,852
-200 Reduced 2.38%
8,214 $714,000
Q2 2019

Jul 26, 2019

SELL
$75.4 - $92.8 $13,119 - $16,147
-174 Reduced 2.03%
8,414 $768,000
Q1 2019

May 09, 2019

BUY
$75.32 - $86.15 $376 - $430
5 Added 0.06%
8,588 $825,000
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $13,388 - $15,486
-200 Reduced 2.28%
8,583 $740,000
Q2 2018

Aug 10, 2018

SELL
$64.91 - $73.36 $3,180 - $3,594
-49 Reduced 0.55%
8,783 $663,000
Q1 2018

May 15, 2018

SELL
$70.39 - $84.15 $32,942 - $39,382
-468 Reduced 5.03%
8,832 $714,000
Q4 2017

Feb 13, 2018

BUY
$72.33 - $77.64 $672,669 - $722,052
9,300
9,300 $781,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Aevitas Wealth Management, Inc. Portfolio

Follow Aevitas Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aevitas Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aevitas Wealth Management, Inc. with notifications on news.